Dr Vázquez Costa is MD in Neurology (2012) and PhD in MND (2019). Since 2013 he is devoted to the care of motor neuron disease patients and in 2020 he was granted a Juan Rodés excellence contract from the Carlos III Health Institute, to coordinate the motor neuron disease unit at Hospital la Fe, a referral national and European unit. He is member of the Spanish research network for rare diseases (CIBERER), the European Reference Network for Neuromuscular Diseases (ERN-NMD), the European Network to Cure ALS (ENCALS) and the TRICALS consortium. He also chairs the Spanish ALS Consortium (SPAIN-ALS) and co-chairs the ALS Genetic Spanish consortium (ALSGESCO). Dr Vázquez Costa has participated in more than 20 research projects and in more than 30 clinical trials in both ALS and SMA, and has published over 100 articles in indexed journals in neuromuscular diseases. He has carried out research stays at the Psychiatry department of the Universitätsklinikum in Freiburg (Germany) and at the Martinos Center for Biomedical Imaging in Boston (USA). His research focus on motor neuron diseases (ALS and 5q SMA), with a especial interest in biomarkers, genetics and therapies.
Dr Vázquez Costa is MD in Neurology (2012) and PhD in MND (2019). Since 2013 he is devoted to the care of motor neuron disease patients and in 2020 he was granted a Juan Rodés excellence contract from the Carlos III Health Institute, to coordinate the motor neuron disease unit at Hospital la Fe, a referral national and European unit. He is member of the Spanish research network for rare diseases (CIBERER), the European Reference Network for Neuromuscular Diseases (ERN-NMD), the European Network to Cure ALS (ENCALS) and the TRICALS consortium. He also chairs the Spanish ALS Consortium (SPAIN-ALS) and co-chairs the ALS Genetic Spanish consortium (ALSGESCO). Dr Vázquez Costa has participated in more than 20 research projects and in more than 30 clinical trials in both ALS and SMA, and has published over 100 articles in indexed journals in neuromuscular diseases. He has carried out research stays at the Psychiatry department of the Universitätsklinikum in Freiburg (Germany) and at the Martinos Center for Biomedical Imaging in Boston (USA). His research focus on motor neuron diseases (ALS and 5q SMA), with a especial interest in biomarkers, genetics and therapies.